Answers are grounded in this paper and cite their sources.
This proof-of-concept study employing a proteomic discovery platform offers insight into statin effects on novel immune pathways relevant to ASCVD progression in HIV. Novel biomarker discovery may enhance precision medicine strategies to estimate the efficacy of targeted therapies to reduce ASCVD progression and events in HIV.
No takes yet. Share an insight, caveat, or question.
deFilippi et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: